FOUR BLADDER TUMOR MARKERS HAVE A DISAPPOINTINGLY LOW SENSITIVITY FOR SMALL SIZE AND LOW GRADE RECURRENCE-Reference-Cited by-同舟云学术

FOUR BLADDER TUMOR MARKERS HAVE A DISAPPOINTINGLY LOW SENSITIVITY FOR SMALL SIZE AND LOW GRADE RECURRENCE

Published:2002-01 Issue:1 Volume:167 Page:80-83
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BOMAN HANS¹,HEDELIN HANS¹,HOLMäNG STEN¹

Affiliation:

1. From the Department of Surgery, Alingsås Lasarett, Alingsås, Departments of Urology, Kärnsjukhuset, Skövde and Sahlgrenska University Hospital, Göteborg, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference12 articles.

1. The value of exfoliative urine cytology in combination with flexible cystoscopy in the diagnosis of recurrent transitional cell carcinoma of the urinary bladder;Loh;Br J Urol,1996

2. Value of urine cytology versus bladder washing in bladder cancer;Matzkin;Urology,1992

3. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer;Sarosdy;J Urol,1995

4. Noninvasive detection of bladder cancer with the BTA stat test;Pode;J Urol,1999

5. Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer;Raitanen;J Urol,2000

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study;Bladder Cancer;2024-03-12

2. Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers;International Journal of Molecular Sciences;2023-09-21

3. Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer;Cureus;2023-06-12

4. Urine biomarkers in bladder cancer — current status and future perspectives;Nature Reviews Urology;2023-05-24

5. Urine Biomarkers for the Diagnosis of Bladder Cancer: A Network Meta-Analysis;UROL J;2021